| NCT Number | NCT06228677 |
| Lead Sponsor | First Affiliated Hospital of Chengdu Medical College |
| Conditions | Resistant Hypertension, Secondary Hypertension, Secondary Hypertension to Endocrine Disorders, Primary Aldosteronism |
| Enrollment | 196 participants |
| Start Date | 2023-09-18 |
| Primary Completion | 2026-06-30 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2024-01-29 |